TapewireFind a company

person · Reporting owner

PATUSKY CHRISTOPHER

Disclosed activity across 1 company

Tapewire entity
29035
SEC CIK
0001231427

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
UNITED THERAPEUTICS CorpUTHR · Entity 664DirectorJuly 22, 2026July 23, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

UNITED THERAPEUTICS Corp

Report date July 22, 2026 · Filed July 23, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $527.07 · Expires 2033-07-22Direct2,380 Reported balance After 2026-07-22 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-07-22 · Grant · Acquired 2,380 · Balance 2,380

F1: Annual non-employee director award.

F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.

Common StockSEC Table I · non-derivativeDirect2,410 Reported balance Holding disclosure · report date 2026-07-22 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,410

Filing footnotes · ownership attribution and instrument terms

F1: Annual non-employee director award.

F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 07, 2023 Filed Nov 8, 2023 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-23-014891 · form4-11082023_041102.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $230.44 $460,880.00
Disclosure

SEC source: 0001415889-23-014891 · form4-11082023_041102.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,684

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $88.03 $176,060.00
Disclosure

SEC source: 0001415889-23-014891 · form4-11082023_041102.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 17, 2023 Filed Aug 18, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-23-012408 · form4-08182023_040805.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 17, 2023 Filed Aug 18, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $228.12 $456,240.00
Disclosure

SEC source: 0001415889-23-012408 · form4-08182023_040805.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,684

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 17, 2023 Filed Aug 18, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $88.03 $176,060.00
Disclosure

SEC source: 0001415889-23-012408 · form4-08182023_040805.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 10:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 GrantRestricted Stock Unit · Derivative 900 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-23-011150 · form4-07172023_060708.xml · derivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900

Underlying: Common Stock · 900 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 10:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 GrantStock Options · Derivative 2,280 $0.00 Strike: $229.81 $0.00
Disclosure

SEC source: 0001415889-23-011150 · form4-07172023_060708.xml · derivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,280

Underlying: Common Stock · 2,280 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-23-007817 · form4-05112023_040511.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $212.24 $424,480.00
Disclosure

SEC source: 0001415889-23-007817 · form4-05112023_040511.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,684

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $88.03 $176,060.00
Disclosure

SEC source: 0001415889-23-007817 · form4-05112023_040511.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 15, 2023 Filed Mar 16, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-23-005017 · form4-03162023_040304.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 15, 2023 Filed Mar 16, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $217.50 $435,000.00
Disclosure

SEC source: 0001415889-23-005017 · form4-03162023_040304.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 15, 2023 Filed Mar 16, 2023 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $88.03 $176,060.00
Disclosure

SEC source: 0001415889-23-005017 · form4-03162023_040304.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-23-000308 · form4-01042023_040101.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $273.32 $546,640.00
Disclosure

SEC source: 0001415889-23-000308 · form4-01042023_040101.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $88.03 $176,060.00
Disclosure

SEC source: 0001415889-23-000308 · form4-01042023_040101.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 17, 2022 Filed Nov 18, 2022 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 SaleCommon Stock 100 $262.61 $26,261.00
Disclosure

SEC source: 0001415889-22-011591 · form4-11182022_041101.xml · nonDerivative · entry 3

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 1,100

Read SEC document
November 16, 2022 Filed Nov 18, 2022 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 1,500 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-22-011591 · form4-11182022_041101.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 1,500 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 16, 2022 Filed Nov 18, 2022 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 1,500 $261.05 $391,575.00
Disclosure

SEC source: 0001415889-22-011591 · form4-11182022_041101.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 16, 2022 Filed Nov 18, 2022 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 1,500 $88.03 $132,045.00
Disclosure

SEC source: 0001415889-22-011591 · form4-11182022_041101.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 1,500 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-22-008821 · form4-08182022_040802.xml · derivative · entry 7

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Common Stock · 1,500 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 1,500 $0.00 Strike: $63.90 $0.00
Disclosure

SEC source: 0001415889-22-008821 · form4-08182022_040802.xml · derivative · entry 6

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2023-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 1,500 $221.63 $332,445.00
Disclosure

SEC source: 0001415889-22-008821 · form4-08182022_040802.xml · nonDerivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 1,500 $88.03 $132,045.00
Disclosure

SEC source: 0001415889-22-008821 · form4-08182022_040802.xml · nonDerivative · entry 3

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 1,500 $221.63 $332,445.00
Disclosure

SEC source: 0001415889-22-008821 · form4-08182022_040802.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 1,500 $63.90 $95,850.00
Disclosure

SEC source: 0001415889-22-008821 · form4-08182022_040802.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
July 08, 2022 Filed Jul 8, 2022 21:45 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 GrantStock Options · Derivative 4,980 $0.00 Strike: $240.20 $0.00
Disclosure

SEC source: 0001415889-22-007604 · form4-07082022_020730.xml · derivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,980

Underlying: Common Stock · 4,980 shares

Expires 2032-07-07

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

Read SEC document
May 17, 2022 Filed May 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $63.90 $0.00
Disclosure

SEC source: 0001415889-22-005241 · form4-05182022_040501.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 2,000 shares

Expires 2023-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
May 17, 2022 Filed May 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $190.99 $381,980.00
Disclosure

SEC source: 0001415889-22-005241 · form4-05182022_040501.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
May 17, 2022 Filed May 18, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $63.90 $127,800.00
Disclosure

SEC source: 0001415889-22-005241 · form4-05182022_040501.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $63.90 $0.00
Disclosure

SEC source: 0001415889-22-003960 · form4-04082022_040418.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 2,000 shares

Expires 2023-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $190.11 $380,220.00
Disclosure

SEC source: 0001415889-22-003960 · form4-04082022_040418.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 20:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $63.90 $127,800.00
Disclosure

SEC source: 0001415889-22-003960 · form4-04082022_040418.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 15, 2022 Filed Mar 16, 2022 20:35 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-22-003051 · form4-03162022_040307.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 15, 2022 Filed Mar 16, 2022 20:35 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $178.82 $357,640.00
Disclosure

SEC source: 0001415889-22-003051 · form4-03162022_040307.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 15, 2022 Filed Mar 16, 2022 20:35 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $88.03 $176,060.00
Disclosure

SEC source: 0001415889-22-003051 · form4-03162022_040307.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 11, 2021 Filed Nov 12, 2021 21:35 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $63.90 $0.00
Disclosure

SEC source: 0001127602-21-028989 · form4.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 2,000 shares

Expires 2023-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 11, 2021 Filed Nov 12, 2021 21:35 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $200.90 $401,800.00
Disclosure

SEC source: 0001127602-21-028989 · form4.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 11, 2021 Filed Nov 12, 2021 21:35 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $63.90 $127,800.00
Disclosure

SEC source: 0001127602-21-028989 · form4.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 08, 2021 Filed Nov 8, 2021 21:30 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 SaleCommon Stock 2,300 $200.16 $460,368.00
Disclosure

SEC source: 0001127602-21-028600 · form4.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:34 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $63.90 $0.00
Disclosure

SEC source: 0001127602-21-023280 · form4.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 2,000 shares

Expires 2023-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:34 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,000 $206.09 $412,180.00
Disclosure

SEC source: 0001127602-21-023280 · form4.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,980

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:34 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 2,000 $63.90 $127,800.00
Disclosure

SEC source: 0001127602-21-023280 · form4.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
July 08, 2021 Filed Jul 9, 2021 20:59 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 GrantStock Options · Derivative 6,450 $183.98 Strike: $183.98 $1,186,671.00
Disclosure

SEC source: 0001127602-21-021765 · form4.xml · derivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,450

Underlying: Common Stock · 6,450 shares

Expires 2031-07-08

F1 · shares: Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders.

F2 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

Read SEC document
June 26, 2021 Filed Jun 29, 2021 20:36 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionRestricted Stock Units · Derivative 1,680 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-21-020804 · form4.xml · derivative · entry 3

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,680 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

Read SEC document
June 26, 2021 Filed Jun 29, 2021 20:36 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionCommon Stock 1,680 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-020804 · form4.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares received upon vesting of restricted stock units on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock.

Read SEC document
May 10, 2021 Filed May 10, 2021 20:31 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 SaleCommon Stock 100 $190.52 $19,052.00
Disclosure

SEC source: 0001127602-21-016063 · form4.xml · nonDerivative · entry 3

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 1,200

Read SEC document
May 06, 2021 Filed May 10, 2021 20:31 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Exercise / conversionShare Tracking Award · Derivative 2,500 $0.00 Strike: $63.90 $0.00
Disclosure

SEC source: 0001127602-21-016063 · form4.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,500

Underlying: Common Stock · 2,500 shares

Expires 2023-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
May 06, 2021 Filed May 10, 2021 20:31 UTC UNITED THERAPEUTICS Corp UTHR · Entity 664 Disposition to issuerCommon Stock 2,500 $192.07 $480,175.00
Disclosure

SEC source: 0001127602-21-016063 · form4.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,300

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.